0000885590-11-000021.txt : 20110411
0000885590-11-000021.hdr.sgml : 20110408
20110411190057
ACCESSION NUMBER: 0000885590-11-000021
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20101222
FILED AS OF DATE: 20110411
DATE AS OF CHANGE: 20110411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loberg Philip Walden Jr
CENTRAL INDEX KEY: 0001508799
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 11753583
MAIL ADDRESS:
STREET 1: 31121 BROOKS STREET
CITY: LAGUNA BEACH
STATE: CA
ZIP: 92651
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
BUSINESS PHONE: 905 286-3000
MAIL ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4/A
2010-12-22
2010-12-27
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001508799
Loberg Philip Walden Jr
C/O 7150 MISSISSAUGA ROAD
MISSISSAUGA
A6
L5N 8M5
ONTARIO, CANADA
0
1
0
0
EVP, Interim CFO
Common Stock, no par value
2010-12-22
4
A
0
694
0
A
130065
D
Represents dividend equivalents accrued on performanced bases restricted share units (PSUs) as a result of a dividend paid on the common stock of Valeant Pharmaceuticals International, Inc. on December 22, 2010.
This amendment is being filed to correct the number of PSUs that were reported in the original filing.
By: Angie Palmer for Philip Loberg
2011-04-11